The risk that changes to or the introduction of laws and regulations, including the Pharmaceuticals and Medical Devices Act and the Specified Commercial Transactions Act, will restrict business activities involving pharmaceuticals, door-to-door sales and other activities. Unlike the risks associated with intensified competition resulting from the relaxation of sales regulations or the continuation of pharmaceutical approvals and licenses, this risk concerns changes themselves to laws and regulations affecting multiple sales and business activities.